MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

MYCN is the most powerful prognostic factor in cases of older children. However, how MYCN is related to the prognosis of infantile cases is not clear. A mass screening program was carried out by measuring urinary catecholamine metabolites (VMA and HVA) from 6-month-old infants. Of 2084 cases detecte...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Iehara, T, Hosoi, H, Akazawa, K, Matsumoto, Y, Yamamoto, K, Suita, S, Tajiri, T, Kusafuka, T, Hiyama, E, Kaneko, M, Sasaki, F, Sugimoto, T, Sawada, T
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2006
Gaiak:
Molecular Diagnostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361271/
https://ncbi.nlm.nih.gov/pubmed/16670717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603149
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak